1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Nasal Bleeding: new trials by email Literature Review of Nasal Bleeding trials Research Report on Nasal Bleeding
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intranasal Bevacizumab for HHT-Related Epistaxis Bevacizumab, Placebo (Saline) - HHT, Hereditary Hemorrhagic Telangiectasia | Phase 4 | Completed | Stanford University | 40 | 2014-08-04 | 2021-09-01 |
Epistaxis (1) · Telangiectasia, Hereditary Hemorrhagic (1)
Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1)
Bevacizumab (1) · Fluoridation (1) · Sodium Chloride (1)
United States (1)